OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.440
-0.020 (-1.37%)
At close: Jun 5, 2026, 4:00 PM EDT
1.460
+0.020 (1.39%)
After-hours: Jun 5, 2026, 7:47 PM EDT

OPKO Health Revenue

OPKO Health had revenue of $124.20M in the quarter ending March 31, 2026, a decrease of -17.18%. This brings the company's revenue in the last twelve months to $432.67M, down -37.24% year-over-year. In the year 2025, OPKO Health had annual revenue of $606.90M, down -14.90%.

Revenue (ttm)
$432.67M
Revenue Growth
-37.24%
P/S Ratio
1.87
Revenue / Employee
$255,439
Employees
2,275
Market Cap
1.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.90M-106.24M-14.90%
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.71M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 20201.44B533.48M59.15%
Dec 31, 2019901.94M-88.33M-8.92%
Dec 31, 2018990.27M24.26M2.51%
Dec 31, 2017966.01M-151.48M-13.56%
Dec 31, 20161.12B625.75M127.25%
Dec 31, 2015491.74M400.61M439.63%
Dec 31, 201491.13M-5.41M-5.60%
Dec 31, 201396.53M49.49M105.19%
Dec 31, 201247.04M19.07M68.14%
Dec 31, 201127.98M-515.00K-1.81%
Dec 31, 201028.49M24.08M544.95%
Dec 31, 20094.42M-5.02M-53.20%
Dec 31, 20089.44M8.59M1,014.52%
Dec 31, 2007847.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
NeoGenomics745.97M
Veracyte541.74M
GeneDx Holdings442.68M
CareDx412.82M
Castle Biosciences339.92M
Fulgent Genetics320.35M
Adaptive Biotechnologies295.41M
Revenue Rankings